How Much Weight Do You Lose a Week on Zepbound?

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Zepbound, works by mimicking two hunger-regulating hormones (GLP-1 and GIP) that signal fullness and reduce appetite. Clinical trials show that participants on tirzepatide lose significantly more weight than those on diet and exercise alone—but the pace varies from person to person, and understanding why matters for setting realistic goals.

Typical Weekly Weight Loss Timeline with Tirzepatide

Most people do not see rapid drops in the first one to two weeks after starting tirzepatide. Your body needs time to adjust to the medication, and your dose typically starts low and increases gradually over several weeks. This ramp-up period allows your system to tolerate the drug while minimizing side effects.

By week three to four, as your dose reaches therapeutic levels, many patients report noticing reduced appetite and beginning to lose weight. Weekly loss at this stage often ranges from 0.5 to 1.5 pounds per week, with faster losses typically seen in the first month as initial water weight and reduced calorie intake combine.

After the first month, weight loss often steadies to 1–2 pounds per week for many patients, though some experience faster or slower rates. By months three through six, cumulative weight loss ranges from 10 to 25 pounds in clinical observations, depending on adherence, diet quality, and individual metabolism. The SURMOUNT trials showed that tirzepatide users lost approximately 21% of their starting body weight over 72 weeks at the highest dose.

Why Your Weekly Weight Loss May Differ from Others

Genetics plays a major role in how your body responds to tirzepatide and how quickly you lose weight. Variations in the GLP1R gene (like rs6923761) and the GIPR gene (rs1800437) influence how effectively your cells recognize and respond to these hunger-suppressing hormones. Someone with a genetic variant that enhances GLP1 receptor sensitivity may see faster appetite reduction and earlier weight loss than someone without that variant.

Your starting weight, age, sex, and metabolic rate also shape your timeline. Individuals with higher starting weights often see larger absolute weight losses in the first weeks, while older adults or those with slower metabolisms may experience more gradual loss. Additionally, how strictly you follow a supportive diet and exercise routine directly affects the scale—tirzepatide suppresses appetite, but it does not eliminate the need for mindful eating choices.

PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and identifies your unique genetic profile across 49 peptides related to appetite, satiety, and weight regulation. This test reveals whether you carry variants in FTO (rs9939609) and MC4R (rs17782313) genes that influence hunger signaling, helping your provider adjust expectations and strategy based on your biology rather than guessing.

What Happens if Weight Loss Slows or Plateaus

Weight loss plateaus are normal and expected, especially after the initial three to six months. Your body adapts to lower calorie intake, and the rate of weight loss naturally slows as you approach a new equilibrium. This does not mean the medication has stopped working; it means your metabolism has adjusted to your lower weight and calorie deficit.

If you experience a plateau, your provider may recommend increasing your dose (if you have not reached the maximum), adjusting your nutrition plan, or increasing physical activity. Some patients benefit from taking a short break before resuming, which can reset the appetite-suppressing effect. Genetic testing through PlexusDx can also reveal whether certain metabolic pathways are limiting your response, allowing your doctor to consider alternative compounds like semaglutide or a dual-compound approach.

Understanding Individual Variation and Setting Realistic Goals

Clinical trial data shows that while average weight loss is substantial, individual outcomes range widely. In the SURMOUNT-3 trial, some participants lost 5% of their body weight while others on the same dose and protocol lost 25% or more. This spread highlights why comparing your progress to someone else's is often misleading and why personalized medicine—including genetic insights—matters.

A realistic goal is to expect gradual, consistent weight loss of 1–2 pounds weekly once you reach a stable dose, with the understanding that this rate will likely decrease over time as your body adjusts. Rather than fixating on weekly numbers, tracking non-scale victories (improved energy, better sleep, reduced cravings, clothes fitting differently) often provides a more complete picture of success. PlexusDx provides compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with your dose adjusted as needed without price changes, removing the cost barrier to finding your optimal therapeutic level.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I expect to lose in my first week on Zepbound?

Most people do not see significant weight loss in the first week because doses start low and increase gradually. By week three to four, as your dose reaches therapeutic levels, you may begin losing 0.5–1.5 pounds weekly. Expecting 1–2 pounds per week after the first month is a realistic benchmark.

Is 1–2 pounds per week considered fast or slow weight loss?

The Centers for Disease Control recommends 1–2 pounds per week as a safe, sustainable rate of weight loss. Tirzepatide typically supports this target, especially in months one through six. Faster initial loss (particularly water weight) may occur, but this slower pace reduces muscle loss and improves long-term adherence.

Can I take tirzepatide through PlexusDx, and how does pricing work?

Yes, PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan from licensed 503A compounding pharmacies, available in all 50 states without insurance. Your dose may need to go up, but your price won't—PlexusDx charges a flat monthly rate regardless of dose level, making it easy to find your optimal therapeutic dose.

What if my weight loss is slower than 1 pound per week?

Slower weight loss can result from genetics, metabolic adaptation, or adherence factors. PlexusDx's Precision Peptide Genetic Test identifies variants in GIPR and FTO, and MC4R genes that influence your metabolic response, helping your provider adjust your strategy. Genetic insights may reveal whether switching compounds or adding a dual-compound therapy like GLP-Squared is a better fit.

How does the Precision Peptide Genetic Test help me lose weight faster?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Zepbound For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.